By 2028, More Than Half of Enterprise GenAI Models Will Be Domain-Specific
Domain-specific AI will power over 50% of enterprise GenAI models by 2028, up from 20% today. DSLMs deliver 85-97% accuracy in regulated industries while running on models 100x smaller than general LLMs. Med-PaLM achieves 95% medical accuracy. Harvey AI reaches $8B valuation with 97% lawyer preference. 68% of manufacturers expect measurable cost reductions. GenAI models market exceeds $25B in 2026 heading to $75B by 2029. Vertical AI market projected to surpass $100B by 2032 and could grow 10x larger than legacy SaaS.